• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苏丹女性局部晚期乳腺癌患者的临床病理特征

Clinicopathological profile of female Sudanese patients with locally advanced breast cancer.

作者信息

Ahmed Awad Ali Mohamed

机构信息

Faculty of Medicine, University of Medical Sciences and Technology, Khartoum, Sudan. Tel.: +249 912802545; E-mail:

出版信息

Breast Dis. 2014;34(3):131-4. doi: 10.3233/BD-140363.

DOI:10.3233/BD-140363
PMID:24448698
Abstract

BACKGROUND

In Sudan, breast cancer is one of the most common malignancy affecting women and the incidence rates appear to be rising. Unfortunately, most of the patients presented in advanced stage.

OBJECTIVE

To obtain information on demographic characteristics, clinicopathological profile and factors related to late presentation.

MATERIALS AND METHODS

Descriptive study. 144 patients who presented from April 2009 through May 2011 with locally advanced breast cancer were included in this study.

RESULTS

144 patients ranging in age from 25-71 years (mean 47 years) were included in the study. Of these 62.5% were premenopausal women. More than 60% of the patients presented after > 1 year following onset of symptoms. 68% of patients attributed their late presentation for lack of education and financial aspects.

CONCLUSION

Our study shows that locally advanced breast cancer patients presented at a younger age. Lack of education, financial issues and dependency on traditional medicine are encountered for this late presentation. We suggest that the attitude of Sudanese females towards breast cancer has to change through continuous but targeted public education.

摘要

背景

在苏丹,乳腺癌是影响女性的最常见恶性肿瘤之一,且发病率似乎在上升。不幸的是,大多数患者就诊时已处于晚期。

目的

获取有关人口统计学特征、临床病理特征以及与晚期就诊相关因素的信息。

材料与方法

描述性研究。本研究纳入了2009年4月至2011年5月期间就诊的144例局部晚期乳腺癌患者。

结果

本研究纳入了年龄在25 - 71岁(平均47岁)的144例患者。其中62.5%为绝经前女性。超过60%的患者在症状出现1年以上后才就诊。68%的患者将其晚期就诊归因于缺乏教育和经济方面的原因。

结论

我们的研究表明,局部晚期乳腺癌患者就诊年龄较轻。晚期就诊的原因包括缺乏教育、经济问题以及对传统医学的依赖。我们建议通过持续且有针对性的公众教育来改变苏丹女性对乳腺癌的态度。

相似文献

1
Clinicopathological profile of female Sudanese patients with locally advanced breast cancer.苏丹女性局部晚期乳腺癌患者的临床病理特征
Breast Dis. 2014;34(3):131-4. doi: 10.3233/BD-140363.
2
Breast cancer clinicopathological presentation, gravity and challenges in Eritrea, East Africa: management practice in a resource-poor setting.东非厄立特里亚的乳腺癌临床病理表现、严重程度和挑战:资源匮乏环境下的管理实践。
S Afr Med J. 2013 Jun 5;103(8):526-8. doi: 10.7196/samj.6829.
3
Frequency and correlation of molecular subtypes of breast cancer with clinicopathological features.乳腺癌分子亚型的频率及其与临床病理特征的相关性。
J Ayub Med Coll Abbottabad. 2014 Jul-Sep;26(3):290-3.
4
Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.新辅助密集剂量阿霉素、环磷酰胺随后紫杉醇化疗对乳腺癌生物学标志物雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER 2)及Ki-67指数变化的评估
J BUON. 2013 Apr-Jun;18(2):366-71.
5
Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers.晚期乳腺癌复发的预测。传统及现代病理和分子标志物。
Surg Oncol Clin N Am. 1995 Oct;4(4):601-32.
6
Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.早期激素受体阳性乳腺癌患者的死亡率:丹麦基于人群的队列研究。
J Natl Cancer Inst. 2011 Sep 21;103(18):1363-72. doi: 10.1093/jnci/djr299. Epub 2011 Aug 31.
7
Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.雌激素和孕激素受体在原发性可手术乳腺癌中的预后意义
Jpn J Clin Oncol. 1990 Sep;20(3):271-80.
8
Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.加利福尼亚州 1999-2004 年浸润性乳腺癌女性中,根据雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体 2(HER2)定义的乳腺癌亚型。
Breast J. 2009 Nov-Dec;15(6):593-602. doi: 10.1111/j.1524-4741.2009.00822.x. Epub 2009 Sep 17.
9
Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study.基于免疫组化生物标志物的分子乳腺癌亚型在西班牙人群中的分布和预后。
Gynecol Oncol. 2013 Sep;130(3):609-14. doi: 10.1016/j.ygyno.2013.05.039. Epub 2013 Jun 6.
10
Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer.局部晚期乳腺癌新辅助化疗早期失败的临床病理特征。
Cancer Chemother Pharmacol. 2014 Sep;74(3):521-9. doi: 10.1007/s00280-014-2542-5. Epub 2014 Jul 22.

引用本文的文献

1
Delayed breast cancer presentation, diagnosis, and treatment in Kenya.肯尼亚乳腺癌的延迟就诊、诊断和治疗。
Breast Cancer Res Treat. 2023 Dec;202(3):515-527. doi: 10.1007/s10549-023-07067-y. Epub 2023 Sep 5.
2
Locally advanced breast cancer treated with neoadjuvant chemotherapy: Is breast-conserving surgery feasible?新辅助化疗治疗局部晚期乳腺癌:保乳手术是否可行?
Ann Med Surg (Lond). 2020 Dec 26;62:95-97. doi: 10.1016/j.amsu.2020.12.039. eCollection 2021 Feb.
3
Strengthening Laboratory Diagnostic Capacity to Support Cancer Care in Uganda.
加强实验室诊断能力,支持乌干达的癌症护理。
Am J Clin Pathol. 2021 Jul 6;156(2):205-213. doi: 10.1093/ajcp/aqaa218.
4
A Case of Locally Advanced Breast Cancer in a 59-Year-Old Man Requiring a Modified Approach to Management.一名59岁男性局部晚期乳腺癌病例:需采用改良管理方法
Am J Case Rep. 2019 Apr 17;20:531-536. doi: 10.12659/AJCR.915377.
5
Axillary Lymph Node Dissection for Breast Cancer: Efficacy and Complication in Developing Countries.乳腺癌腋窝淋巴结清扫术:发展中国家的疗效与并发症
J Glob Oncol. 2018 Oct;4:1-8. doi: 10.1200/JGO.18.00080.
6
EBV Associated Breast Cancer Whole Methylome Analysis Reveals Viral and Developmental Enriched Pathways.EB病毒相关乳腺癌全基因组甲基化分析揭示病毒和发育富集通路
Front Oncol. 2018 Aug 13;8:316. doi: 10.3389/fonc.2018.00316. eCollection 2018.
7
Delayed presentation and diagnosis of breast cancer in African women: a systematic review.非洲女性乳腺癌的延迟就诊与诊断:一项系统评价
Ann Epidemiol. 2017 Oct;27(10):659-671.e7. doi: 10.1016/j.annepidem.2017.09.007. Epub 2017 Sep 22.